argus

Syngene International Limited

NSE: SYNGENEINE398R0102216,183 Cr

Timeline

Time (IST)TypeMEventSrc
29 Apr, 06:46 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Dividend Updatesbse
29 Apr, 06:45 pmSyngene International Limited has informed the Exchange that Board of Directors at its meeting held on April 29, 2026, recommended Final Dividend of Rs. 1.25 per equity share.nse
29 Apr, 06:35 pmSyngene International Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.nse
23 Apr, 02:29 pmBiocon Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.nse
15 Apr, 05:49 pmSyngene International Ltd - 539268 - Board Meeting Intimation for Considering And Approving The Audited Standalone And Consolidated Financial Results For The Quarter And Year Ending March 31, 2026; And To Consider The Recommendation Of Final Dividend, If Any.bse
15 Apr, 05:05 pmSyngene International Ltd - 539268 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011bse
10 Apr, 09:57 amSyngene International Ltd - 539268 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
29 Mar, 01:57 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
29 Mar, 01:52 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
27 Mar, 07:00 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Change in Managementbse
27 Mar, 06:54 pmSyngene International Limited has informed the Exchange about change in Managementnse
14 Mar, 06:55 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
14 Mar, 06:53 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
06 Mar, 04:10 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Change in Managementbse
06 Mar, 04:04 pmSyngene International Limited has informed the Exchange about change in Managementnse
18 Feb, 04:52 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
18 Feb, 04:50 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
17 Feb, 05:58 pmSyngene International Ltd - 539268 - Disclosures under Reg. 29(1) of SEBI (SAST) Regulations, 2011bse
14 Feb, 09:35 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
14 Feb, 09:31 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
14 Feb, 09:28 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
14 Feb, 09:17 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
14 Feb, 09:14 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
14 Feb, 09:11 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
29 Jan, 06:05 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
29 Jan, 05:50 pmSyngene International Limited has informed the Exchange about Transcriptnse
23 Jan, 05:23 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcomebse
23 Jan, 05:12 pmSyngene International Limited has informed the Exchange about Link of Recordingnse
23 Jan, 12:31 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
23 Jan, 12:24 pmSyngene International Limited has informed the Exchange about Investor Presentationnse
22 Jan, 07:13 pmSyngene International Limited has informed the Exchange regarding 'Board comments on fine levied by the Exchanges'.nse
22 Jan, 07:05 pmSyngene International Limited has informed the Exchange regarding 'Intimation of amendment of Code of Practices and Procedures for Fair Disclosure of Unpublished Price Sensitive Information (UPSI) of the Company'.nse
22 Jan, 06:42 pmSyngene International Limited has informed the Exchange regarding Board meeting held on January 22, 2026.nse
22 Jan, 06:36 pmSyngene International Limited has informed the Exchange regarding a press release dated January 22, 2026, titled "Nine months revenue from operations up 3% year-on-year to Rs. 2,702 Cr - Third quarter revenue from operations down 3% year-on-year to Rs. 917 Cr".nse
22 Jan, 06:36 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
22 Jan, 06:33 pmSyngene International Ltd - 539268 - Unaudited Financial Results For Quarter & Nine Months Ended December 31, 2025.bse
22 Jan, 06:32 pmSyngene International Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.nse
19 Jan, 09:31 amSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Press Release / Media Releasebse
19 Jan, 09:30 amSyngene International Limited has informed the Exchange regarding a press release dated January 19, 2026, titled "Syngene International extends long-term research collaboration with Bristol Myers Squibb until 2035".nse
09 Jan, 07:00 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
09 Jan, 06:54 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
08 Jan, 12:52 pmSyngene International Ltd - 539268 - Board Meeting Intimation for Considering And Approving The Un-Audited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ending December 31, 2025.bse
30 Dec, 11:42 pmSyngene International Ltd - 539268 - Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015bse
30 Dec, 11:34 pmSyngene International Limited has informed the Exchange about Pendency of Litigation(s)/dispute(s) or the outcome impacting the Companynse
23 Dec, 09:25 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Acquisitionbse
23 Dec, 09:18 pmSyngene International Limited has informed the Exchange about Acquisitionnse
17 Dec, 01:03 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Investor Presentationbse
17 Dec, 12:57 pmSyngene International Limited has informed the Exchange about Investor Presentationnse
18 Nov, 10:09 pmSyngene International Ltd - 539268 - Announcement under Regulation 30 (LODR)-Change in Managementbse
18 Nov, 10:02 pmSyngene International Limited has informed the Exchange about change in Managementnse